Literature DB >> 10155309

Economic decision making in healthcare. A standard approach to discounting health outcomes.

A L Hillman1, M S Kim.   

Abstract

Mesh：

Year:  1995        PMID： 10155309     DOI： 10.2165/00019053-199507030-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  24 in total

1.  Economic analysis in randomized control trials.

Authors:  M E Adams; N T McCall; D T Gray; M J Orza; T C Chalmers
Journal:  Med Care       Date:  1992-03       Impact factor: 2.983

2.  Discounting in cost-effectiveness analysis of healthcare programmes.

Authors:  D A Katz; H G Welch
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

3.  Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: an issue for debate?

Authors:  D Coyle; K Tolley
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

4.  Discounting health increments.

Authors:  J K Hammitt
Journal:  J Health Econ       Date:  1993-04       Impact factor: 3.883

Review 5.  Interpretation of "cost-effective" and soundness of economic evaluations in the pharmacy literature.

Authors:  J T Lee; L A Sanchez
Journal:  Am J Hosp Pharm       Date:  1991-12

6.  Guidelines for the clinical and economic evaluation of health care technologies.

Authors:  G Guyatt; M Drummond; D Feeny; P Tugwell; G Stoddart; R B Haynes; K Bennett; R Labelle
Journal:  Soc Sci Med       Date:  1986       Impact factor: 4.634

Review 7.  Clinical economics. A guide to the economic analysis of clinical practices.

Authors:  J M Eisenberg
Journal:  JAMA       Date:  1989-11-24       Impact factor: 56.272

8.  Decision analysis: introductory lectures on choices under uncertainty. 1968.

Authors:  H Raiffa
Journal:  MD Comput       Date:  1993 Sep-Oct

9.  Economic evaluation of neonatal intensive care of very-low-birth-weight infants.

Authors:  M H Boyle; G W Torrance; J C Sinclair; S P Horwood
Journal:  N Engl J Med       Date:  1983-06-02       Impact factor: 91.245

10.  Cost-effective care of end-stage renal disease: a billion dollar question.

Authors:  S D Roberts; D R Maxwell; T L Gross
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391
View more
  4 in total

Review 1.  Theoretical arguments for the discounting of health consequences: where do we go from here?

Authors:  Angelina Lazaro
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 2.  Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart disease.

Authors:  A J Coukell; M I Wilde
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

3.  Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programme.

Authors:  Marcello Tirani; Michela Meregaglia; Alessia Melegaro
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

4.  The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients.

Authors:  Yue Zhong; Joshua T Cohen; Scott Goates; Menghua Luo; Jeffrey Nelson; Peter J Neumann
Journal:  Appl Health Econ Health Policy       Date:  2017-02       Impact factor: 2.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.